MULTIPLE DOSAGE FORMS COMPRISING FENOFIBRATE OR FENOFIBRIC ACID IN COMBINATION WITH HMG CO A REDUCTASE INHIBITORS SUCH AS STATINS

摘要

The present invention relates to pharmaceutical formulations comprising a HMG-CoA reductase enzyme inhibitor and a fibric acid derivative in order to be used in the treatment of hyperlipoproteinemia, hypertriglyceridemia, hypercholesterolemia, myocardial infarction and stroke and/or related diseases.